Aevi Genomic Medicine to Present at the H.C. Wainwright 20th Annual Global Investment Conference
Aevi Genomic Medicine Announces Capital Raise of $4.9M to Accelerate Part B of the ASCEND Trial
Aevi Genomic Medicine Announces Completion of Enrollment in Part A of Phase 2 ASCEND Trial in ADHD
Leaders in genetic science and commercial drug development
Discover the future of novel genetic therapies currently being researched by Aevi Genomic Medicine.
Presentations, information, and news